| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property and equipment held for sale | 313 | |||
| Restricted cash | 1,906 | |||
| Prepaid expenses | 366 | |||
| Other current assets | 1,571 | |||
| Cash and cash equivalents | 16,688 | |||
| Operating lease right of use assets, current | 265 | |||
| Total current assets | 21,109 | |||
| Other assets, noncurrent | 0 | |||
| Operating lease right of use assets | 0 | |||
| Property and equipment, net | 0 | |||
| Total assets | 21,109 | |||
| Accrued expenses and other current liabilities | 3,247 | |||
| Operating lease liability, current | 411 | |||
| Accounts payable | 2,687 | |||
| Total current liabilities | 6,345 | |||
| Other liabilities, noncurrent | 0 | |||
| Operating lease liability, noncurrent | 0 | |||
| Total liabilities | 6,345 | |||
| Accumulated deficit | -264,891 | |||
| Common stock, 0.001 par value 490,000,000 shares authorized at june 30, 2025 and december 31, 2024, respectively, 23,140,691 and 23,136,617 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively | 23 | |||
| Additionalpaid-incapital | 279,834 | |||
| Accumulated other comprehensive loss | -202 | |||
| Total stockholders' equity | 14,764 | |||
| Total liabilities and stockholders' equity | 21,109 | |||
Turnstone Biologics Corp. (TSBX)
Turnstone Biologics Corp. (TSBX)